On Thursday shares of Bellerophon Therapeutics LLC (NASDAQ:BLPH) closed at $8.52. Bellerophon Therapeutics, Inc. (NASDAQ:BLPH), announced the appointments of Scott P. Bruder, M.D., Ph.D. and Scott Huennekens as independent directors. Mr. Huennekens will also serve as a member of the Audit Committee and Dr. Bruder will serve as a member of the Compensation Committee.
Second Sight Medical Products, Inc. (NASDAQ:EYES) in last trading activity advanced 9.29% to close at $12.71. Company weekly performance is 4.87% while its quarterly performance stands at 39.06%. Second Sight Medical Products, Inc. (NASDAQ:EYES) is -47.09% away from its 52 week high. Second Sight Medical Products Inc. (NASDAQ:EYES) on Wednesday reported a loss of $5 million in its first quarter. The Sylmar, California-based company said it had a loss of 14 cents per share. Losses, adjusted for stock option expense, were 12 cents per share.
On last trading day Barracuda Networks, Inc. (NYSE:CUDA) decreased -0.74% to close at $39.16. Its volatility for the week is 2.91% while volatility for the month is 4.13%. CUDA’s sales growth for past 5 years was 17.50% and its EPS growth for past 5 years was -69.10%. Barracuda Networks, Inc. (NYSE:CUDA) monthly performance is -11.00%. New Barracuda Networks, Inc. (NYSE:CUDA) Load Balancer FDC Delivers High Performance per Dollar with 40 Gbps Throughput at Industry Disruptive Price. Barracuda Load Balancer FDC Provides Customers High Throughput Load Balancing Optimized for Virtualized Data Centers.
Dominion Resources Black Warrior Trust (NYSE:DOM) has institutional ownership stands at 5.70%. In last trading activity company’s stock closed at $6.23.
On last trading day Plug Power Inc. (NASDAQ:PLUG) advanced 0.38% to close at $2.63. Its volatility for the week is 6.91% while volatility for the month is 4.17%. PLUG’s sales growth for past 5 years was 39.20% and its EPS growth for past 5 years was 29.20%. Plug Power Inc. (NASDAQ:PLUG) monthly performance is -5.40%. Plug Power (NASDAQ:PLUG)‘s stock had its “outperform” rating reiterated by analysts at Cowen and Company in a research report issued to clients and investors on Thursday. They currently have a $3.50 price objective on the stock.